Eve Elizabeth Slater - Net Worth and Insider Trading

Eve Elizabeth Slater Net Worth

The estimated net worth of Eve Elizabeth Slater is at least $541,450 dollars as of 2024-11-13. Eve Elizabeth Slater is the Director of Vertex Pharmaceuticals Inc and owns about 1,105 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $541,450. Details can be seen in Eve Elizabeth Slater's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eve Elizabeth Slater has not made any transactions after 2007-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eve Elizabeth Slater

To

Eve Elizabeth Slater Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eve Elizabeth Slater owns 3 companies in total, including Aceragen Inc (ACGN) , Vertex Pharmaceuticals Inc (VRTX) , and Innoviva Inc (INVA) .

Click here to see the complete history of Eve Elizabeth Slater’s form 4 insider trades.

Insider Ownership Summary of Eve Elizabeth Slater

Ticker Comapny Transaction Date Type of Owner
ACGN Aceragen Inc 2010-06-16 director
VRTX Vertex Pharmaceuticals Inc 2007-05-29 director
INVA Innoviva Inc 2005-12-08 director

Eve Elizabeth Slater Latest Holdings Summary

Eve Elizabeth Slater currently owns a total of 1 stock. Eve Elizabeth Slater owns 1,105 shares of Vertex Pharmaceuticals Inc (VRTX) as of May 29, 2007, with a value of $541,450.

Latest Holdings of Eve Elizabeth Slater

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VRTX Vertex Pharmaceuticals Inc 2007-05-29 1,105 490.00 541,450

Holding Weightings of Eve Elizabeth Slater


Eve Elizabeth Slater Form 4 Trading Tracker

According to the SEC Form 4 filings, Eve Elizabeth Slater has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 10,000 shares on May 29, 2007, which brought Eve Elizabeth Slater around $304,200.

Insider Trading History of Eve Elizabeth Slater

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eve Elizabeth Slater Trading Performance

GuruFocus tracks the stock performance after each of Eve Elizabeth Slater's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eve Elizabeth Slater is -3.39%. GuruFocus also compares Eve Elizabeth Slater's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eve Elizabeth Slater within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eve Elizabeth Slater's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eve Elizabeth Slater

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.6 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.97 LIMIT LIMIT LIMIT LIMIT LIMIT

Eve Elizabeth Slater Ownership Network

Ownership Network List of Eve Elizabeth Slater

No Data

Ownership Network Relation of Eve Elizabeth Slater

Insider Network Chart

Eve Elizabeth Slater Owned Company Details

What does Aceragen Inc do?

Who are the key executives at Aceragen Inc?

Eve Elizabeth Slater is the director of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .

Aceragen Inc (ACGN) Insider Trades Summary

Over the past 18 months, Eve Elizabeth Slater made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net purchase of 21,147 shares made by Pillar Invest Corp , a net sale of 135,672 shares made by Atul Chopra , and a net sale of 3,283 shares made by Vincent Milano .

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 144,824 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 117,859 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aceragen Inc Insider Transactions

No Available Data

Eve Elizabeth Slater Mailing Address

Above is the net worth, insider trading, and ownership report for Eve Elizabeth Slater. You might contact Eve Elizabeth Slater via mailing address: C/o Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Attn: General Counse, Cambridge Ma 02139.